193 related articles for article (PubMed ID: 10881033)
1. In vivo regulation of mu-opioid receptor density and gene expression in CXBK and outbred Swiss Webster mice.
Duttaroy A; Yoburn BC
Synapse; 2000 Aug; 37(2):118-24. PubMed ID: 10881033
[TBL] [Abstract][Full Text] [Related]
2. Role of cAMP-dependent protein kinase (PKA) in opioid agonist-induced mu-opioid receptor downregulation and tolerance in mice.
Shen J; Benedict Gomes A; Gallagher A; Stafford K; Yoburn BC
Synapse; 2000 Dec; 38(3):322-7. PubMed ID: 11020235
[TBL] [Abstract][Full Text] [Related]
3. Role of G(i)alpha2-protein in opioid tolerance and mu-opioid receptor downregulation in vivo.
Yoburn BC; Gomes BA; Rajashekara V; Patel C; Patel M
Synapse; 2003 Feb; 47(2):109-16. PubMed ID: 12454948
[TBL] [Abstract][Full Text] [Related]
4. Opioid agonist and antagonist treatment differentially regulates immunoreactive mu-opioid receptors and dynamin-2 in vivo.
Yoburn BC; Purohit V; Patel K; Zhang Q
Eur J Pharmacol; 2004 Sep; 498(1-3):87-96. PubMed ID: 15363980
[TBL] [Abstract][Full Text] [Related]
5. Opioid receptor upregulation in mu-opioid receptor deficient CXBK and outbred Swiss Webster mice.
Duttaroy A; Shen J; Shah S; Chen B; Sehba F; Carroll J; Yoburn BC
Life Sci; 1999; 65(2):113-23. PubMed ID: 10416817
[TBL] [Abstract][Full Text] [Related]
6. Continuous opioid agonist treatment dose-dependently regulates mu-opioid receptors and dynamin-2 in mouse spinal cord.
Zhang Q; Purohit V; Yoburn BC
Synapse; 2005 Jun; 56(3):123-8. PubMed ID: 15765525
[TBL] [Abstract][Full Text] [Related]
7. Opioid receptor regulation in mice.
Yoburn BC; Billings B; Duttaroy A
J Pharmacol Exp Ther; 1993 Apr; 265(1):314-20. PubMed ID: 8386239
[TBL] [Abstract][Full Text] [Related]
8. Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2.
Pawar M; Kumar P; Sunkaraneni S; Sirohi S; Walker EA; Yoburn BC
Eur J Pharmacol; 2007 Jun; 563(1-3):92-101. PubMed ID: 17349996
[TBL] [Abstract][Full Text] [Related]
9. In vivo homologous regulation of mu-opioid receptor gene expression in the mouse.
Sehba F; Duttaroy A; Shah S; Chen B; Carroll J; Yoburn BC
Eur J Pharmacol; 1997 Nov; 339(1):33-41. PubMed ID: 9450614
[TBL] [Abstract][Full Text] [Related]
10. mu-Opioid receptor internalization-dependent and -independent mechanisms of the development of tolerance to mu-opioid receptor agonists: Comparison between etorphine and morphine.
Narita M; Suzuki M; Narita M; Niikura K; Nakamura A; Miyatake M; Yajima Y; Suzuki T
Neuroscience; 2006; 138(2):609-19. PubMed ID: 16417975
[TBL] [Abstract][Full Text] [Related]
11. Chronic opioid antagonist treatment selectively regulates trafficking and signaling proteins in mouse spinal cord.
Patel CN; Rajashekara V; Patel K; Purohit V; Yoburn BC
Synapse; 2003 Oct; 50(1):67-76. PubMed ID: 12872295
[TBL] [Abstract][Full Text] [Related]
12. NTP Toxicology and Carcinogenesis Studies of Oxazepam (CAS No. 604-75-1) in Swiss-Webster and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Aug; 443():1-321. PubMed ID: 12595920
[TBL] [Abstract][Full Text] [Related]
13. Intracisternal A-particle element in the 3' noncoding region of the mu-opioid receptor gene in CXBK mice: a new genetic mechanism underlying differences in opioid sensitivity.
Han W; Kasai S; Hata H; Takahashi T; Takamatsu Y; Yamamoto H; Uhl GR; Sora I; Ikeda K
Pharmacogenet Genomics; 2006 Jun; 16(6):451-60. PubMed ID: 16708053
[TBL] [Abstract][Full Text] [Related]
14. Opioid agonists differentially regulate mu-opioid receptors and trafficking proteins in vivo.
Patel MB; Patel CN; Rajashekara V; Yoburn BC
Mol Pharmacol; 2002 Dec; 62(6):1464-70. PubMed ID: 12435815
[TBL] [Abstract][Full Text] [Related]
15. Transient upregulation of mu opioid receptor mRNA levels in nucleus accumbens during chronic cocaine administration.
Azaryan AV; Clock BJ; Rosenberger JG; Cox BM
Can J Physiol Pharmacol; 1998 Mar; 76(3):278-83. PubMed ID: 9673791
[TBL] [Abstract][Full Text] [Related]
16. The role of opioid receptor density in morphine tolerance.
Lutfy K; Yoburn BC
J Pharmacol Exp Ther; 1991 Feb; 256(2):575-80. PubMed ID: 1847202
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid hormone regulates the circadian coordination of micro-opioid receptor expression in mouse brainstem.
Yoshida M; Koyanagi S; Matsuo A; Fujioka T; To H; Higuchi S; Ohdo S
J Pharmacol Exp Ther; 2005 Dec; 315(3):1119-24. PubMed ID: 16109741
[TBL] [Abstract][Full Text] [Related]
18. Decrease in delta and mu opioid receptor binding capacity in rat brain after chronic etorphine treatment.
Tao PL; Law PY; Loh HH
J Pharmacol Exp Ther; 1987 Mar; 240(3):809-16. PubMed ID: 3031275
[TBL] [Abstract][Full Text] [Related]
19. Increase of opioid mu-receptor gene expression in streptozotocin-induced diabetic rats.
Cheng JT; Liu IM; Chi TC; Tzeng TF
Horm Metab Res; 2001 Aug; 33(8):467-71. PubMed ID: 11544560
[TBL] [Abstract][Full Text] [Related]
20. A lack of mu-opioid receptors modulates the expressions of neuropeptide Y and substance P mRNA.
Yoo JH; Cho JH; Lee SY; Loh HH; Ho IK; Jang CG
Neurosci Lett; 2005 Aug 12-19; 384(1-2):29-32. PubMed ID: 15885902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
